• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX (TRIVASCULAR INC.) OVATION IX; ILIAC LIMB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX (TRIVASCULAR INC.) OVATION IX; ILIAC LIMB Back to Search Results
Model Number TV-IL1422140-J
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Failure of Implant (1924); No Code Available (3191)
Date of Event 03/25/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Endologix will continue to investigate the reported event.The patient medical records and imaging studies have been requested for further evaluation by a clinical specialist.A final report will be submitted once the investigation of the reported event has concluded.
 
Event or Problem Description
An ovation ix abdominal stent graft system was implanted to treat an abdominal aortic aneurysm (aaa).Reportedly, the patient was diagnosed with renal insufficiency prior to the initial ovation implant (pre-existing and non-aaa-related).The ovation stent graft system landed and deployed as expected during the initial procedure.Approximately three (3) years post op, the routine follow-up non-con ct identified aaa sac growth from 6cm to 7cm compared to the previous year in addition to a possible type 1b or type ii endoleak.The patient is being monitored.
 
Additional Manufacturer Narrative
At the completion of the clinical evaluation and based on the information received, there was unsubstantial evidence to support the reported event of an indeterminate endoleak due to a lack of relevant imaging.The procedure-related harms and device, user, procedure, or anatomy relatedness of this event could not be determined.The final patient status was reported to be under surveillance pending a diagnostic angiogram.The manufacturing lot review confirmed all devices met specifications prior to release.These types of events will be monitored and trended as part of the quality system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
ILIAC LIMB
Manufacturer (Section D)
ENDOLOGIX (TRIVASCULAR INC.)
3910 brickway blvd.
santa rosa CA 95403
MDR Report Key8537501
Report Number3008011247-2019-00066
Device Sequence Number10854601
Product Code MIH
UDI-Device IdentifierM701TVIL1422140J1
UDI-Public+M701TVIL1422140J1/$$3190429FS02121619S
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/29/2019
Device Model NumberTV-IL1422140-J
Device Catalogue NumberTV-IL1422140-J
Device Lot NumberFS021216-19
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 03/27/2019
Supplement Date Received by Manufacturer03/27/2019
Initial Report FDA Received Date04/22/2019
Supplement Report FDA Received Date06/20/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
OVATION IX EXTENDER (LN FS100815-14).; OVATION IX ILIAC LIMB (LN FS100615-08).; OVATION IX MAIN BODY (LN FS030216-40).; OVATION IX EXTENDER (LN FS100815-14); OVATION IX ILIAC LIMB (LN FS100615-08); OVATION IX MAIN BODY (LN FS030216-40)
Outcome Attributed to Adverse Event Other;
Patient Age87 YR
-
-